US2016355818A1PendingUtilityA1

Method of fixing and expressing physiologically active substance

Assignee: STELIC INST OF REGENERATIVE MEDICINE STELIC INST & COPriority: Jun 29, 2007Filed: Aug 19, 2016Published: Dec 8, 2016
Est. expiryJun 29, 2027(~0.9 yrs left)· nominal 20-yr term from priority
A61K 31/713A61K 9/10A61P 19/02A61K 9/0019A61K 9/0024A61P 9/10A61P 17/02A61K 9/08A61K 48/0075A61K 31/7105C12N 15/113A61K 9/0053A61K 31/7088A61K 31/396A61P 1/00
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides methods for retaining and expressing physiologically active substances in a target tissue-specific-manner, by administering the physiologically active substances to target submucous tissue. Specifically, the present inventors demonstrated that, when physiologically active substances were directly administered into submucous tissues without using a carrier, the physiologically active substances were effectively and safely retained at the administration sites over long periods without loss and diffusion, and produced the effect acting in a reservoir-like fashion. The physiologically active substances administered as described above were demonstrated to produce the therapeutic effect without having an influence on organs other than the administered organ.

Claims

exact text as granted — not AI-modified
1 . A method for retaining and expressing a physiologically active substance in a target submucous tissue-specific manner, wherein the physiologically active substance is administered into the submucous tissue. 
     
     
         2 . The method of  claim 1 , wherein the physiologically active substance is selected from nucleic acids, proteins, carbohydrates, lipids, or low-molecular-weight compounds. 
     
     
         3 . The method of  claim 2 , wherein the nucleic acid is an siRNA. 
     
     
         4 . The method of any one of  claims 1  to  3 , wherein the physiologically active substance is administered in combination with a pharmaceutically acceptable carrier.

Join the waitlist — get patent alerts

Track US2016355818A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.